Categories for Presentation (en)

Finwire interview

December 20, 2023 9:00 am Published by jonas

Redwood Pharma at Aktieportföljen Live

October 14, 2022 11:23 am Published by jonas

BioStock Life Science Spring Summit 2022

June 13, 2022 1:10 pm Published by jonas

Redwood Pharma – Interview with CEO

November 30, 2021 2:28 pm Published by jonas

Aktiedagen Lund January 27 2021

February 3, 2021 9:15 am Published by jonas

About the successful results of RP101 and what lies ahead

January 29, 2021 12:28 pm Published by jonas

Stora Aktiedagen Göteborg

December 1, 2020 12:21 pm Published by jonas

RP101 Phase II clinical results

April 6, 2020 11:17 am Published by jonas

Stora Aktiedagen Stockholm 2018 – Redwood Pharma

March 22, 2020 11:22 pm Published by jonas

Aktiedagen Lund 30 januari 2018 – Redwood Pharma

March 22, 2020 11:22 pm Published by jonas

Redwood Pharma

We develop ophthalmic drugs that address major medical needs. We focus on early-stage clinical development. Our long-term strategy is to enter into licence agreements with other drug companies who will in turn introduce products for the global market.

Redwood Pharma

Vi utvecklar ögonläkemedel för stora medicinska behov. Tonvikten ligger på tidig klinisk utveckling. Den långsiktiga strategin är att teckna licensavtal med andra läkemedelsbolag, som i sin tur kan introducera produkterna på världsmarknaden.